These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 26105428)

  • 1. Opioid Prescription, Morbidity, and Mortality in US Transplant Recipients.
    Abbott KC; Fwu CW; Eggers PW; Eggers AW; Kline PP; Kimmel PL
    Transplantation; 2018 Jun; 102(6):994-1004. PubMed ID: 29319627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arteriolar hyalinization at 0-hour biopsy predicts long-term graft function in deceased kidney transplantation.
    Murata M; Tasaki M; Saito K; Nakagawa Y; Ikeda M; Akiyama M; Imai N; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2024 Mar; 31(3):287-294. PubMed ID: 38062869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney donor age of 50 years or above is a risk factor for calcineurin inhibitor-induced nephrotoxicity.
    Takada Y; Tanabe T; Sasaki H; Tsujimoto T; Hotta K; Okada K; Shiono Y; Minami K; Tanaka H; Harada H
    Clin Transplant; 2024 Jan; 38(1):e15196. PubMed ID: 37975424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of academic delay post-pediatric kidney transplant in the USA.
    Mathew J; Tumin D; Beng-Ongey H
    Pediatr Nephrol; 2024 Jul; ():. PubMed ID: 38963554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KidneyCare Guided Immuno-Optimization in Renal Allografts: The KIRA Protocol.
    Gray JN; Wolf-Doty T; Sulejmani N; Gaber O; Axelrod D; Abdalla B; Danovitch G
    Methods Protoc; 2020 Sep; 3(4):. PubMed ID: 33007896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma FGF21 Concentration in Kidney Transplant Patients-Results from Prospective and Cross-Sectional Studies.
    Bartmańska M; Wiecek A; Adamczak M
    J Clin Med; 2024 Jul; 13(14):. PubMed ID: 39064306
    [No Abstract]   [Full Text] [Related]  

  • 7. Physical activity and its impact on cardiovascular health in pediatric kidney transplant recipients.
    Kohlmeier L; von der Born J; Lehmann E; Fröde K; Grabitz C; Greiner AS; Albrecht AA; Memaran N; Sugianto RI; Tegtbur U; Schmidt BMW; Kanzelmeyer N; Melk A
    Pediatr Nephrol; 2024 May; 39(5):1587-1598. PubMed ID: 38103064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Graft Survival After Diagnosis of Post-kidney Transplant Malignancy: Using Cox Proportional Hazard Model.
    Rahimi Foroushani A; Salesi M; Rostami Z; Mehrazmay AR; Mohammadi J; Einollahi B; Eshraghian MR
    Iran Red Crescent Med J; 2015 Nov; 17(11):e20281. PubMed ID: 26734477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin Inhibition in Deceased Organ Donors: A Systematic Review and Meta-analysis of Preclinical Studies.
    D'Aragon F; Rousseau W; Breau R; Aminaei D; Ichai C; Boyd GJ; Burns KEA; Cardinal H; Carrier FM; Chassé M; Chaudhury P; Dhanani S; English SW; Frenette AJ; Hanna S; Knoll G; Lauzier F; Oczkowski S; Rochwerg B; Shamseddin K; Slessarev M; Treleaven D; Turgeon AF; Weiss MJ; Selzner M; Meade MO
    Transplant Direct; 2023 Sep; 9(9):e1519. PubMed ID: 37649790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Variants in Calcineurin Inhibitor Pharmacokinetic and Pharmacodynamic Genes and Renal Dysfunction in Adult Heart Transplant Recipients.
    Oreschak K; Saba LM; Rafaels N; Ambardekar AV; Deininger KM; Page RL; Lindenfeld J; Aquilante CL
    Front Genet; 2021; 12():658983. PubMed ID: 33868389
    [No Abstract]   [Full Text] [Related]  

  • 11. A multimodal aftercare intervention improves the outcome after kidney transplantation - results of the KTx360° aftercare program using claims data.
    Pape L; DeZwaan M; Nöhre M; Klewitz F; Kyaw Tha Tun E; Prüfe J; Schiffer L; Gertges R; Schieffer E; Albrecht A; Boeck HT; Kliem V; Wolff JK; Ludolph P; Talamo J; Nolting HD; Lieb M; Erim Y; Krusemark H; Gefeller O; Kaiser I; Tegtbur U; Schiffer M;
    EClinicalMedicine; 2024 Jul; 73():102652. PubMed ID: 38841709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy.
    Cavagna L; Seminari E; Zanframundo G; Gregorini M; Di Matteo A; Rampino T; Montecucco C; Pelenghi S; Cattadori B; Pattonieri EF; Vitulo P; Bertani A; Sambataro G; Vancheri C; Biglia A; Bozzalla-Cassione E; Bonetto V; Monti MC; Ticozzelli E; Turco A; Oggionni T; Corsico A; Bertuccio F; Zuccaro V; Codullo V; Morosini M; Marena C; Gnecchi M; Pellegrini C; Meloni F
    Microorganisms; 2020 Jun; 8(7):. PubMed ID: 32629788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexities and outcomes of pulmonary hypertension in kidney transplant patients: a comprehensive review.
    Lentine KL; Levine DJ; Runo JR; Caliskan Y; Costa S; Lam NN; Axelrod DA; Woodside KJ
    Turkish J Nephrol; 2024 Jan; 33(1):8-26. PubMed ID: 38213512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cyclosporine in uterine transplantation.
    Saso S; Logan K; Abdallah Y; Louis LS; Ghaem-Maghami S; Smith JR; Del Priore G
    J Transplant; 2012; 2012():134936. PubMed ID: 22132302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on the iris pattern as a risk factor for skin cancer development in immunosuppressed renal transplant recipients.
    Bao H; Wu X
    J Eur Acad Dermatol Venereol; 2024 Jun; ():. PubMed ID: 38860685
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-Term Follow-Up for Recipients of Genetically Modified Cells: A Team Effort.
    Heslop HE
    Transplant Cell Ther; 2024 Mar; 30(3):247-249. PubMed ID: 38485335
    [No Abstract]   [Full Text] [Related]  

  • 17. PP106. Risk of long term renal graft loss after pregnancy in renal transplant recipients immunosuppressed with calcineurin inhibitors.
    Cararach V; Oppenheimer F; Rios J
    Pregnancy Hypertens; 2012 Jul; 2(3):297. PubMed ID: 26105428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
    Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion to everolimus in kidney transplant recipients: to believe or not believe?
    Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A
    Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.